Hermann V, Batalov A, Smakotina S, et al. First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study. Lupus Science & Medicine 2019;6:e000354. doi: 10.1136/lupus-2019-000354.
The authors want to alert the readers to the error identified in Supplementary file 7.
The original Supplementary file 7 included the number of patients (n) in the full analysis set for each cenerimod dosage. The revised file has been amended to show the correct n numbers, which is the number of patients included in the modified pharmacodynamics set (mPD set).
